Please login to the form below
clinical
This page shows the latest clinical news and features for those working in and with pharma, biotech and healthcare.
Mereo’s shareholders back OncoMed takeover
It went public in 2013, raising $81m, but a couple of years later started to suffer a series of major clinical setbacks that all-but obliterated its clinical pipeline. ... Those programmes will slot into Mereo’s pipeline alongside its other clinical
Latest news
-
Genfit claims FDA breakthrough status for liver disease drug
Elafibranor has shown promising anticholestatic effects in a Phase 2 clinical trial,” said Pascal Birman, Deputy Chief Medical Officer, Genfit.
-
With Spiriva under pressure, Boehringer moves to bolster pipeline
Forges alliance with PureTech Health
-
Novartis makes case for gene therapy Zolgensma in SMA
Now, phase 3 results from the clinical programme STR1VE have shown a prolonged event-free survival and an early and rapid increase in CHOP-INTEND scores, which are a series of
-
Stem cell transplant firms Kiadis and CytoSen join forces
Assuming Kiadis’ shareholders give their blessing to the deal – and institutional investors holding 31.5% of the stock have already done so – the combined company will have two clinical-stage programmes
-
Akcea steals march on Alnylam with NICE approval
This is vital for Tegsedi, which had generally been seen as the runner-up to Onpattro in terms of the data produced in their pivotal clinical trials.
More from news
Approximately 185 fully matching, plus 4,153 partially matching documents found.
Latest Intelligence
-
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
personalisation. Patient engagement at scientific congresses. Presentation at scientific congresses is generally the first step in communicating clinical trial results to the healthcare professional audience. ... The American Society of Clinical Oncology
-
The first, my last, my everything
In the past, industry has taken a traditional view of patient value, typically basing it on clinical outcomes and disease progression. ... They may have a life-threatening condition and be willing to risk severe side effects to be part of an early stage
-
Vertex: a vision of treating all CF patients worldwide draws closer
These include alpha-1 antitrypsin deficiency and focal segmental glomerulosclerosis. It’s also working with CRISPR Therapeutics on phase 1/2 clinical trials for CTX001, a gene editing therapy for patients
-
Galderma launches Rosacea awareness campaign
Rosacea normally presents varied clinical characteristics, of which the most common are flushing, permanent erythema and inflammatory lesions. ... As a leader in rosacea, Galderma is committed to gathering patient insights that enable us to tailor our
-
The Orkambi row explained
March 2019: House of Commons health select committee inquiry into Okambi row hears evidence from Vertex, NHSE, NICE and patient and clinical representatives.
More from intelligence
Approximately 14 fully matching, plus 519 partially matching documents found.
Latest appointments
-
New faces at BioStrata, P\S\L Group and FCB Health
Joining the company as a science writer, Caroline Chambers comes with a life science background having spent five years in clinical veterinary practice.
-
New hires at Ferring, Flexion and Immunocore
He also worked on progressing the company’s pipeline of TCR candidate through clinical development. ... His appointment as Head of R&D strengthens Immunocore's leadership team and supports us as we advance our growing pipeline of TCR candidates through
-
New hires at Nanoform, Leo Pharma and Calliditas
and bringing products to market will play a key role as we progress development of Nefecon through phase 3 clinical trials”, said Renée Aguiar-Lucander, CEO of Calliditas Therapeutics.
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Her appointment will significantly strengthen Immunocore as we advance our lead candidate, IMCgp100, towards commercialisation, and our growing pipeline of TCR candidates through clinical development.”. ... Verona Pharma appoints chief medical officer.
-
New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics
Mader brings a track record of drug discovery experience to the biotech, most recently working for Eli Lilly, where she contributed to the development of multiple clinical candidates. ... There, he was responsible for preclinical development, CMC, and
More from appointments
Approximately 3 fully matching, plus 504 partially matching documents found.
Latest from PMHub
-
Havas Lynx Launches Specialist Clinical Trial Recruitment Agency, Havas Lynx Faze
44 (0) 161 228 7756. Address:. 52 Princess Street. Manchester. M1 6JX.
-
Adding different perspectives to scientific communications at Porterhouse Medical
Lauren graduated from the University of Cambridge, School of Clinical Medicine and worked in clinical practice for five years.
-
New opportunities in emerging markets
Until recently, multinational pharmaceutical and life sciences companies have focused their clinical research efforts/clinical development programs almost exclusively on mature markets: North America, Europe and Japan in particular.
-
Eoin McAtamney announced as Managing Director of Ashfield Ireland
With experience managing commercial and clinical teams in a number of different environments, I understand the challenges in ensuring the patient experiences the best po. ... Nigel Mansford, Regional President Ashfield Commercial and Clinical EUCAN,
-
Peadar Coyle announced as Business Development Director for Ashfield Ireland
We have a heritage in offering the best representatives to the Irish pharmaceutical sector and we’re really excited to see how both the clinical and contact centre services evolve.
More from PMHub
Approximately 26 fully matching, plus 437 partially matching documents found.
Featured jobs
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
-
Senior Medical Writer
-
Competitive salary and benefits
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Senior Medical Writer
-
Salary TBC
-
Director – Healthcare PR
-
Salary TBC
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
-
Account Director, Medical Education
-
Salary TBC
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Skills in Healthcare
At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
